Wird geladen...
Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials
Simon’s two-stage design and the admissible two-stage design have been commonly used in practice for single-arm phase II clinical trials when the primary endpoint is binary. The ethical benefit of the two-stage design over the single-stage design is attained by the early termination of the trial whe...
Gespeichert in:
| Veröffentlicht in: | Oncotarget |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Impact Journals LLC
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6611508/ https://ncbi.nlm.nih.gov/pubmed/31303960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26981 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|